Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

China Survey of Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease

NCT02606851 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02606851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02606851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
China Survey of Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 4, 2015
Completion date
December 28, 2016
Enrollment
1,000 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

patients with typical symptoms of gerd (gerd q >= 8)